REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/06/2026
Back to search
Official data from USPTO
VICORE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/06/2026
Trademark type
Word
Nice classes
5, 42
Filing date
01/23/2020
Registration date
07/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/06/2021
Last transaction
07/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SE
Examiner
PODESTA, GIDETTE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vicore Pharma AB
Representatives
Sarah J. Schneider Sheridan Ross P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and medical preparations for human useprescription drugspillstabletscapsulescapletsliquid drops sachets for the treatment fibrotic lung disease
Class 42
Medical and pharmacological research services; medical and pharmacological research services within the fields of pulmonary diseasescardiovascular diseasesautoimmune and inflammatory diseasesfibrotic diseases and kidney diseases; medical and pharmacological research services within the fields of pulmonary fibrosisipfpulmonary sarcoidosis and diffuse systemic sclerosisin particular in the field of lung manifestations; pharmaceutical research and development; scientific research and development; medical research laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; pharmaceutical drug delivery system development services; pharmaceutical drug development servicespreparation and/or formulation of pharmaceuticals; medical product testing services; clinical research and professional expertise relating thereto in the nature of professional expertise in the field of clinical research for others; all of the foregoing services for the treatment of fibrotic lung disease
Publications
History of USPTO decisions and trademark events.
34 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/22/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/21/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/01/2021
FIMP
FINAL DISPOSITION PROCESSED
11/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/31/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
02/16/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/24/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2021
PUBO
PUBLISHED FOR OPPOSITION
01/19/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/30/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/16/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/29/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/29/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/29/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/29/2020
RFNT
REFUSAL PROCESSED BY IB
05/29/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/14/2020
RFRR
REFUSAL PROCESSED BY MPU
05/14/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/01/2020
CNRT
NON-FINAL ACTION WRITTEN
04/30/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/28/2020
DOCK
ASSIGNED TO EXAMINER
04/24/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/24/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/23/2020
Continuous trademark protection
Get notified about every new filing that threatens VICORE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.